
YFM makes 2.7x on sale of Mangar Health to PE-backed Winncare Group
YFM Equity Partners has generated a 2.7x return (22% IRR) on the sale of its medical equipment company Mangar Health to IDI-backed Winncare Group.
The sale ends a holding period of four years for YFM’s British Smaller Companies VCT and British Smaller Companies VCT2, both of which backed the original buyout transaction.
Mangar has increased the number of staff by almost 50% under YFM’s ownership and now employs 70 people.
Winncare is a buy-and-build strategy in the medical equipment sector that consists of five European subsidiaries. The group was acquired by IDI for a €17m equity investment in 2014.
Previous funding
YFM acquired Mangar for an enterprise value of approximately £9m in 2014; debt was provided by Clydesdale and Yorkshire Bank.
Company
Mangar was founded in 1981 and is headquartered in Powys, Wales. The company designs and manufactures inflatable bathing and lifting devices. The business generated sales of £8.8m and operating profit of £566,084 in 2017, according to publicly available documents.
People
YFM Equity Partners – Ian Waterfield (partner).
Mangar Health – Simon Claridge (CEO).
Advisers
Vendor – KPMG (corporate finance); Addleshaw Goddard (legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater